Enrasentan Uses, Dosage, Side Effects and more
| Trade Name | Enrasentan |
| Generic | Enrasentan |
| Enrasentan Other Names | Enrasentan |
| Type | |
| Formula | C29H30O8 |
| Weight | Average: 506.551 Monoisotopic: 506.194067926 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in congestive heart failure, chronic obstructive pulmonary disease (COPD), and benign prostatic hyperplasia.
